69: Outcomes with nintedanib and docetaxel in patients with relapsed NSCLC adenocarcinoma treated within the UK Nintedanib Individual Patient Supply programme. (January 2017) - Tokaca, N.; Crawford, M.S.; Greystoke, A.; Appel, W.; Lal, R.; Steele, N.; Ali, C.; Bezecny, P.; Fernando, S.; Karapanagiotou, E.; Skailes, G.; Dorey, N.; et al.